Veracyte

Performance

About Veracyte

Veracyte is a molecular diagnostics company specializing in cancer genomics to inform diagnosis and treatment across multiple cancer types. Its tests provide physicians with molecular insights to guide personalized treatment decisions and improve patient care, with a global reach through a centralized CLIA lab in the US and distributed tests for international markets. The portfolio includes Afirma for thyroid, Decipher for prostate and bladder cancers, Prosigna for breast cancer, and Percepta for lung cancer, among others, supported by collaborative research and evidence generation. Headquartered with offices in the United States and international locations, Veracyte focuses on advancing precision cancer care worldwide.